Phase I and pharmacokinetic study of a micronized formulation of carboxyamidotriazole, a calcium signal transduction inhibitor: toxicity, bioavailability and the effect of food.

Berlin J, Tutsch KD, Arzoomanian RZ, Alberti D, Binger K, Feierabend C, Dresen A, Marnocha R, Pluda J, Wilding G
Clin Cancer Res. 2002 8 (1): 86-94

PMID: 11801543

MeSH Terms (21)

Adult Aged Aged, 80 and over Antineoplastic Agents Biological Availability Calcium Calcium Channel Blockers Capsules Diet Therapy Drug Administration Schedule Female Gels Hematopoiesis Humans Intestinal Absorption Male Maximum Tolerated Dose Middle Aged Neoplasms Nervous System Triazoles

Connections (1)

This publication is referenced by other Labnodes entities: